PIIND PI Industries Q1 FY27 results (Apr–Jun 2026) and concall
PI Industries reported a revenue of ₹17,023 million for Q1 FY27 with a strong 57% gross margin and 22% EBITDA margin. The domestic business showed robust 12% volume growth, and biologicals grew 50%. While the global and domestic agrochemical markets faced headwinds and pricing pressure, the company continues to invest significantly in R&D and new growth platforms like Pharma and Biologicals, leading to short-term subsidiary losses but positioning for long-term growth.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q1 FY27: revenue down 10.4%, net profit down 39.0% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2,221 | 1,901 | 1,787 | 1,900 | 1,872 −16% | 1,376 −28% | 1,565 −12% | 1,702 −10% |
| EBITDA | 628 | 512 | 456 | 519 | 541 −14% | 302 −41% | 337 −26% | 367 −29% |
| Net profit | 508 | 373 | 330 | 400 | 409 −19% | 311 −17% | 200 −39% | 244 −39% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.





